STOCK TITAN
  1. Home
  2. News
  3. MASI

Masimo Corp - MASI STOCK NEWS

Welcome to our dedicated news page for Masimo (Ticker: MASI), a resource for investors and traders seeking the latest updates and insights on Masimo.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Masimo's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Masimo's position in the market.

News
Masimo Announces New Member of the Board of Directors
Rhea-AI Summary
Masimo (NASDAQ: MASI) appoints Rolf A. Classon, an experienced medical technology executive, to its Board of Directors. Mr. Classon has held various management positions with major healthcare companies and brings extensive industry expertise to Masimo.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.71%
Tags
management
-
News
Masimo Reports Third Quarter 2023 Financial Results
Rhea-AI Summary
Masimo Corporation (Nasdaq: MASI) announced its third quarter 2023 financial results, reporting consolidated revenue of $478.9 million, with healthcare revenue at $307.8 million and non-healthcare revenue at $171.1 million. GAAP net income per diluted share was $0.20, while non-GAAP net income per diluted share was $0.63. The company also provided updated fourth-quarter 2023 and full-year 2023 financial guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.71%
Tags
earnings
-
News
United States International Trade Commission Issues Exclusion Order for Infringing Apple Watches, Finding that Apple Violated U.S. Trade Laws
Rhea-AI Summary
The United States International Trade Commission (USITC) has recommended a limited exclusion order for Apple Watches that infringe on Masimo's patented light-based pulse oximetry technology. The exclusion is set to go into effect after a 60-day Presidential review period.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
none
News
Masimo to Report Third Quarter 2023 Financial Results after Market Close on Tuesday, November 7
Rhea-AI Summary
Masimo (NASDAQ: MASI) will release third quarter 2023 financial results for the period ended September 30, 2023, after the market closes on Tuesday, November 7, 2023. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.23%
Tags
conferences earnings
-
News
Masimo ORi™ Granted De Novo as the First and Only FDA-Cleared Noninvasive and Continuous Parameter to Provide Insight into Hyperoxia Under Supplemental Oxygen
Rhea-AI Summary
Masimo's ORi granted De Novo by FDA, launching in the U.S. at ANESTHESIOLOGY 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
none
-
News
Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring
Rhea-AI Summary
Masimo receives CE mark for LiDCO board-in-cable module for hemodynamic monitoring
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.17%
Tags
none
News
Masimo to Present in Wells Fargo Healthcare Conference
Rhea-AI Summary
Masimo to participate in Wells Fargo Healthcare Conference on September 8, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
conferences
-
News
Franciscan Missionaries of Our Lady Health System and Masimo Sign Multi-year, System-wide Monitoring Agreement
Rhea-AI Summary
Leading Louisiana and Mississippi Healthcare Provider Standardizes 10 Hospitals on Masimo SET® and Patient SafetyNet™ to Enhance Patient Safety and Improve Patient Outcomes
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.15%
Tags
none
-
News
Masimo Announces Full Market Release of Stork™ Smart Home Baby Monitor
Rhea-AI Summary
Masimo announces full U.S. market release of Stork smart home baby monitoring system
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.03%
Tags
none
News
New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Elderly Patients Undergoing Gastrointestinal Surgery
Rhea-AI Summary
Masimo's noninvasive, continuous PVi reduces cardiopulmonary complications and fluid administered during GI surgery on elderly patients, according to a study. PVi group had significantly lower rate of cardiopulmonary complications (8.4% vs 19.2%) and lower total volume of fluid administered (median 2075 ml vs. 2500 ml).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
none
Stock MASI logo
Masimo Corp

Nasdaq:MASI

MASI Rankings

#971 Ranked by Market Cap
#4202 Ranked by Stock Gains
N/A Ranked by Dividends

MASI Stock Data

7.30B
44.60M
7.71%
96.37%
7.99%
Electromedical and Electrotherapeutic Apparatus Manufacturing
Manufacturing
Link
US
Irvine

About MASI

masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.